Search research articles
Contact Us
Filters
Showing results (621-630 of 670) with videos related to
Page
of 67
Sort By:
Journal of Medicinal Chemistry
|
November 7, 2000
Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects
K S Kim, J S Sack, J S Tokarski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2011
Antitumor and antiangiogenic activities of BMS-690514, an inhibitor of human EGF and VEGF receptor kinase families
Tai W Wong, Francis Y Lee, Stuart Emanuel, et al.
BMC Infectious Diseases
|
August 5, 2021
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
Ashley N Bonheur, Sarah Thomas, Sara H Soshnick, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 2018
Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
David K Williams, Jay A Markwalder, Aaron J Balog, et al.
Cytotherapy
|
January 23, 2025
Human keratinocytes grown at a gas-permeable interface in vitro stratify correctly to generate engineered human epidermis
Vaughan Feisst, Lisa Y Y Zhou, Chun-Jen Jennifer Chen, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors
Robert M Borzilleri, Xiaoping Zheng, Ligang Qian, et al.
Journal of Medicinal Chemistry
|
June 23, 2006
Discovery and evaluation of N-cyclopropyl- 2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5- ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2
Robert M Borzilleri, Rajeev S Bhide, Joel C Barrish, et al.
Chemical Science
|
July 14, 2023
Modulation of IL-17 backbone dynamics reduces receptor affinity and reveals a new inhibitory mechanism
Daniel J Shaw, Lorna C Waters, Sarah L Strong, et al.
Applied Optics
|
April 21, 2010
Large aperture harmonic conversion experiments at LLNL: comments
G J Linford, B C Johnson, J S Hildum, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 10, 2023
Development of a Novel Serological Assay for the Detection of Mpox Infection in Vaccinated Populations
Jennifer L Yates, Danielle T Hunt, Karen E Kulas, et al.
Page
of 67
Search research articles
Search
Showing results (621-630 of 670) with videos related to
Sort By:
Page
of 67
Journal of Medicinal Chemistry
|
November 7, 2000
Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects
K S Kim, J S Sack, J S Tokarski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2011
Antitumor and antiangiogenic activities of BMS-690514, an inhibitor of human EGF and VEGF receptor kinase families
Tai W Wong, Francis Y Lee, Stuart Emanuel, et al.
BMC Infectious Diseases
|
August 5, 2021
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
Ashley N Bonheur, Sarah Thomas, Sara H Soshnick, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 6, 2018
Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
David K Williams, Jay A Markwalder, Aaron J Balog, et al.
Cytotherapy
|
January 23, 2025
Human keratinocytes grown at a gas-permeable interface in vitro stratify correctly to generate engineered human epidermis
Vaughan Feisst, Lisa Y Y Zhou, Chun-Jen Jennifer Chen, et al.
Journal of Medicinal Chemistry
|
June 10, 2005
Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors
Robert M Borzilleri, Xiaoping Zheng, Ligang Qian, et al.
Journal of Medicinal Chemistry
|
June 23, 2006
Discovery and evaluation of N-cyclopropyl- 2,4-difluoro-5-((2-(pyridin-2-ylamino)thiazol-5- ylmethyl)amino)benzamide (BMS-605541), a selective and orally efficacious inhibitor of vascular endothelial growth factor receptor-2
Robert M Borzilleri, Rajeev S Bhide, Joel C Barrish, et al.
Chemical Science
|
July 14, 2023
Modulation of IL-17 backbone dynamics reduces receptor affinity and reveals a new inhibitory mechanism
Daniel J Shaw, Lorna C Waters, Sarah L Strong, et al.
Applied Optics
|
April 21, 2010
Large aperture harmonic conversion experiments at LLNL: comments
G J Linford, B C Johnson, J S Hildum, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 10, 2023
Development of a Novel Serological Assay for the Detection of Mpox Infection in Vaccinated Populations
Jennifer L Yates, Danielle T Hunt, Karen E Kulas, et al.
Page
of 67